Curative Biotechnology Inc (CUBT)

OTC Biotechnology Diagnostics SIC: 2836
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT06070051 Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nu... PHASE1 Active Not Recruiting 56

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis